Fig.1. Decision scheme and decision-making factors for antithrombotic therapy after PCI.

ARC-HBR, Academic Research Consortium for High Bleeding Risk; OAC, oral anticoagulant; ACS, acute coronary syndrome; CCS, chronic coronary syndrome; DES, drug-eluting stent; PCI, percutaneous coronary intervention; DAPT, dual antiplatelet therapy; ASA, acetylsalicylic acid